Generic Diastat AcuDial Availability
Last updated on May 7, 2025.
See also: Generic Diastat
Diastat AcuDial is a brand name of diazepam, approved by the FDA in the following formulation(s):
DIASTAT ACUDIAL (diazepam - gel;rectal)
-
Manufacturer: BAUSCH
Approval date: September 15, 2005
Strength(s): 10MG/2ML (5MG/ML) [RLD] [AB], 20MG/4ML (5MG/ML) [RLD] [AB]
Is there a generic version of Diastat AcuDial available?
Yes. The following products are equivalent to Diastat AcuDial:
diazepam gel;rectal
-
Manufacturer: NOVEL LABS INC
Approval date: May 30, 2023
Strength(s): 10MG/2ML (5MG/ML) [AB], 20MG/4ML (5MG/ML) [AB]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Diastat AcuDial. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: Generic Drug FAQ.
More about Diastat AcuDial (diazepam)
- Check interactions
- Compare alternatives
- Reviews (2)
- Drug images
- Latest FDA alerts (3)
- Side effects
- Dosage information
- During pregnancy
- Drug class: benzodiazepine anticonvulsants
- Breastfeeding
- En español
Patient resources
Other brands
Valium, Valtoco, Diazepam Intensol, Libervant, Zetran
Professional resources
Other brands
Other formulations
Related treatment guides
Related/similar drugs
Lamotrigine
Lamotrigine systemic is used for anxiety, bipolar disorder, borderline personality disorder ...
Lyrica
Lyrica is used to control seizures, treat nerve pain and fibromyalgia. Learn about side effects ...
Mounjaro
Mounjaro is used for type 2 diabetes to help lower blood sugar levels. Mounjaro has also been shown ...
Depakote
Depakote is used to treat various types of seizure disorders. Learn about side effects ...
Ativan
Ativan is a benzodiazepine used to treat anxiety disorders or anxiety associated with depression ...
Valium
Valium is used to treat anxiety disorders, alcohol withdrawal symptoms, or muscle spasms. Learn ...
Phenytoin
Phenytoin is an anti-epileptic drug, also called an anticonvulsant. Learn about side effects ...
Dilantin
Dilantin (phenytoin) is an anti-epileptic drug used to control seizures. Includes Dilantin side ...
Topiramate
Topiramate systemic is used for bipolar disorder, borderline personality disorder, bulimia ...
Levetiracetam
Levetiracetam systemic is used for bipolar disorder, epilepsy, hyperekplexia, neuralgia, new daily ...
Glossary
| Term | Definition |
|---|---|
| Drug Patent | A drug patent is assigned by the U.S. Patent and Trademark Office and assigns exclusive legal right to the patent holder to protect the proprietary chemical formulation. The patent assigns exclusive legal right to the inventor or patent holder, and may include entities such as the drug brand name, trademark, product dosage form, ingredient formulation, or manufacturing process A patent usually expires 20 years from the date of filing, but can be variable based on many factors, including development of new formulations of the original chemical, and patent infringement litigation. |
| Drug Exclusivity | Exclusivity is the sole marketing rights granted by the FDA to a manufacturer upon the approval of a drug and may run simultaneously with a patent. Exclusivity periods can run from 180 days to seven years depending upon the circumstance of the exclusivity grant. |
| RLD | A Reference Listed Drug (RLD) is an approved drug product to which new generic versions are compared to show that they are bioequivalent. A drug company seeking approval to market a generic equivalent must refer to the Reference Listed Drug in its Abbreviated New Drug Application (ANDA). By designating a single reference listed drug as the standard to which all generic versions must be shown to be bioequivalent, FDA hopes to avoid possible significant variations among generic drugs and their brand name counterpart. |
| AB | Products meeting necessary bioequivalence requirements. Multisource drug products listed under the same heading (e.g. identical active ingredients, dosage form, and routes of administration) and having the same strength (see Therapeutic Equivalence-Related Terms, Pharmaceutical Equivalents) generally will be coded AB if a study is submitted demonstrating bioequivalence. In certain instances, a number is added to the end of the AB code to make a three character code (e.g. AB1, AB2, AB7). Three-character codes are assigned only in situations when more than one reference listed drug of the same strength has been designated under the same heading. Two or more reference listed drugs are generally selected only when there are at least two potential reference drug products which are not bioequivalent to each other. If a study is submitted that demonstrates bioequivalence to a specific listed drug product, the generic product will be given the same three-character code as the reference listed drug it was compared against. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
